Director dealing & loan note

RNS Number:4040J
International Medical Devices PLC
07 December 2007

7 December 2007



                       International Medical Devices plc

                            ("IMD" or "the Company")



                Directors Remuneration and Convertible Loan Note



International Medical Devices plc (AIM: INT), the medical supply company
targeting the acute care, aged care, and devices markets, announces that its new
CEO has agreed to take part of his remuneration in shares above the current
market price, and that it has signed a convertible loan note.



Bill McGrath joined the company as Chief Operating Officer on 2 November 2007,
and became the Company's Chief Executive Officer on 3 December 2007.  He has
agreed to convert, in aggregate #70,000 of his remuneration into Ordinary
Shares, at a price higher than today's market price, being 1,125,000 Ordinary
Shares at 4p and 500,000 Ordinary Shares at 5p, being a total of 1,625,000
Ordinary Shares.



The Company has also entered into a two year loan note with Trafalgar Capital
Specialized Investment Fund amounting to #600,000 which carries conversion
rights into Ordinary shares.  IMD intends to utilise the funds in support of the
Company's "buy and build" strategy, relating to potential acquisition
opportunities.  The provider has been issued 329,272 Ordinary Shares on entering
into the agreement.



Application has been made for the above 1,954,272 Ordinary Shares to be admitted
to trading on AIM.  It is expected that admission to trading on AIM will be
effected and dealings in these new Ordinary Shares will commence on 13 December
2007.





Lindsay Sanford, Executive Chairman, said:

"Bill's offer to take part payment in shares above current market price is a
significant vote of confidence in the strength of the Company and its plans for
the future.  We look forward to working with him in his new role as CEO, to
implement a robust business plan to enhance our existing businesses and enable
us to make further acquisitions.



The convertible loan note will help expedite these acquisitions, by giving us
flexible cash flow to cover costs relating to the acquisition of new businesses
to add to our growing portfolio."







For further information, contact:


International Medical Devices        JM Finn                 Parkgreen Communications

Mike Acheson, FD                     Geoff Nash              Simon Robinson / Erica Nelson

[phone]                     [phone]        [phone]






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSUUGUPPUPMGBQ